ad
Ad
No icon

Decesion comes soon after talks with Donald Trump

India lifts the ban on hydroxychloroquine which is used to treat COVID-19 patients

Ad

Hydroxychloroquine is and old and a genetic medicine and used in the treatment of malaria. India have a large source of access for the same as India is worlds no 1 exporter of genetic medicine and Hydroxychloroquine is still used to an large extent in the country for diseases. This Hydroxychloroquine is used during the treatment of malaria but this have recently proved much help for the COVID-19 patients in fast recovery. However there is no conclusive evidence for the same and various Scientist and Doctors across the world are working upon the same. Moreover this medicine is available cheapest along the competitors and hence U.S President Donald Trump may be interested for the same. So far government reports say that except U.S 30 more countries has requested for the same.

 

Hence in view to this the Narendra Modi government has decided to partially lift the ban on the export of two key drugs, hydroxychloroquine and paracetamol, to clear “all existing orders”. This move comes two days after US President Donald Trump requested Prime Minister Narendra Modi for an urgent supply of the drug. Trump Monday said he was unaware that the export of hydroxychloroquine was banned by India and that he didn’t “like that decision”. According to sources, a decision has now been taken by the Modi government to “restrict” the export of hydroxychloroquine and paracetamol, while allowing the shipment of all other medicines under the ‘free’ category on which a ban was imposed last month. The export of hydroxychloroquine and paracetamol will be now taken up on a “case-to-case basis, depending on the availability of stock after meeting domestic requirements,” said a source.“All existing orders will be cleared. The Ministry of External Affairs and Department of Pharma will decide on such allocations depending on humanitarian (COVID) situation,” the source added.

The decision to partially lift the ban on hydroxychloroquine and paracetamol was taken late Monday even as the export of all other key medicines like tinidazole, metronidazole, erythromycin salts, vitamins and others were lifted.

“With regard to paracetamol and Hydroxychloroquine (HCQ), they will be kept in a licensed category and their demand position would be continuously monitored. However, the stock position could allow our companies to meet the export commitments that they had contracted,” said Anurag Srivastava, Spokesperson, Ministry of External Affairs, Tuesday.

Srivastava added that “in view of the humanitarian aspects of the pandemic, it has been decided that India would licence paracetamol and HCQ in appropriate quantities to all our neighbouring countries who are dependent on our capabilities. We will also be supplying these essential drugs to some nations who have been particularly badly affected by the pandemic. We would therefore discourage any speculation in this regard or any attempts to politicise the matter. "I would be surprised if he would, you know, because India does very well with the United States," Trump told reporters during a press briefing at the White House on Monday.

Last month, India imposed a ban on the export on Hydroxychloroquine, on which Trump is now banking heavily for the treatment of COVID-19 patients. India has received similar requests from several other countries including its immediate neighbours Sri Lanka and Nepal. India had said that it is reviewing its export ban order.

Comment As:

Comment (0)